FDA Adverse Event Injury Summary report: N

LINEAR ST

MDR report key: 20444348 · Received October 14, 2024

Report

Report Number
3006630150-2024-06942
Event Type
Injury
Date Received
October 14, 2024
Date of Event
December 6, 2023
Report Date
December 4, 2024
Manufacturer
BOSTON SCIENTIFIC NEUROMODULATION CORPORATION
Product Code
LGW
UDI-DI
08714729767725
PMA / PMN Number
P030017
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
FL, US
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

BLOCK B3: APPROXIMATED BASED ON THE DATE THE MANUFACTURER BECAME AWARE OF THE EVENT. ADDITIONAL SUSPECT MEDICAL DEVICE COMPONENTS INVOLVED IN THE EVENT: PRODUCT FAMILY: SCS-LINEAR LEADS. UPN: M365SC2218500; MODEL: SC-2218-50; SERIAL: (B)(6)/(B)(6)/(B)(6); BATCH: 20162179/7077082/7133851. PRODUCT FAMILY: SCS-LINEAR LEADS: UPN: M365SC2317700; MODEL: SC-2317-70; SERIAL: (B)(6); BATCH: 5098749.

Description of Event or Problem · 0

IT WAS REPORTED THAT FOLLOWING AN IMPLANTABLE PULSE GENERATOR (IPG) REVISION PROCEDURE (MFR. REPORT NO. 3006630150-2024-06941), THE COVERAGE WAS NOT OBTAINED. X-RAY WAS TAKEN AND REVEALED THAT THE SPINAL CORD STIMULATION (SCS) LEAD HAD MIGRATED. THE PATIENT UNDERWENT A LEAD REPLACEMENT PROCEDURE AND WAS DOING WELL POSTOPERATIVELY.

Description of Event or Problem · 0

IT WAS REPORTED THAT FOLLOWING AN IMPLANTABLE PULSE GENERATOR (IPG) REPLACEMENT PROCEDURE. (MFR. REPORT NO. 3006630150-2024-06941), THE COVERAGE WAS NOT OBTAINED. X-RAY WAS TAKEN AND REVEALED SPINAL CORD STIMULATION (SCS) LEAD MIGRATION. THE PATIENT UNDERWENT A LEAD REPLACEMENT PROCEDURE AND WAS DOING WELL POSTOPERATIVELY. ADDITIONAL INFORMATION WAS RECEIVED THAT EXPLANTED PRODUCTS WERE NOT RELEASED BY FACILITY AND WILL NOT BE RETURNED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1811455 LINEAR ST STIMULATOR, SPINAL-CORD, TOTALLY IMPLANTED FOR PAIN RELIEF LGW BOSTON SCIENTIFIC NEUROMODULATION CORPORATION SC-2218-50 20162179 08714729767725

Patients

Seq Age Sex Outcome Treatment
1 76 YR Female Required Intervention